Paper17522507
Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
Clavien PA. Ann Surg, 2007. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection? Papers, record 17522507. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522507
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Interferon-alpha | Major topic |
| Liver Neoplasms | Major topic |
| Chemotherapy, Adjuvant | |
| Combined Modality Therapy | |
| Female | |
| Hepatectomy | |
| Hepatitis B | |
| Humans | |
| Interferon alpha-2 | |
| Liver Transplantation | |
| Male | |
| Neoplasm Recurrence, Local | |
| Neoplasm Staging | |
| Prognosis | |
| Randomized Controlled Trials as Topic | |
| Recombinant Proteins | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 18438131 | Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection? | https://conductscience.org/library/papers/18438131 | PubMed |
| Comment on | 17522506 | A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. | https://conductscience.org/library/papers/17522506 | PubMed |
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8594428 | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8594428 | PubMed |
| 2 | 15048738 | Critical evaluation of the different staging systems for hepatocellular carcinoma. | Br J Surg | 2004 | https://conductscience.org/library/papers/15048738 | PubMed |
| 3 | 7881929 | Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. | Br J Surg | 1995 | https://conductscience.org/library/papers/7881929 | PubMed |
| 4 | 8609071 | A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8609071 | PubMed |
| 5 | 8628336 | Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8628336 | PubMed |
| 6 | 10459961 | Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. | Lancet | 1999 | https://conductscience.org/library/papers/10459961 | PubMed |
| 7 | 15785088 | Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. | Intervirology | 2005 | https://conductscience.org/library/papers/15785088 | PubMed |
| 8 | 15827439 | Surgical therapy of hepatocellular carcinoma. | Eur J Gastroenterol Hepatol | 2005 | https://conductscience.org/library/papers/15827439 | PubMed |
| 9 | 15918144 | Prevention of hepatocellular carcinoma. | Semin Liver Dis | 2005 | https://conductscience.org/library/papers/15918144 | PubMed |
| 10 | 15921814 | Third forum on liver transplantation. Living donor liver transplantation. Who needs it? How to do it? Who should do it? | J Hepatol | 2005 | https://conductscience.org/library/papers/15921814 | PubMed |
| 11 | 16112768 | Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never. | J Hepatol | 2005 | https://conductscience.org/library/papers/16112768 | PubMed |
| 12 | 16897271 | Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. | Ann Surg Oncol | 2006 | https://conductscience.org/library/papers/16897271 | PubMed |
| 13 | 17133492 | Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. | Hepatology | 2006 | https://conductscience.org/library/papers/17133492 | PubMed |
| 14 | 17429086 | Strategies for safer liver surgery and partial liver transplantation. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17429086 | PubMed |
| 15 | 17522506 | A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. | Ann Surg | 2007 | https://conductscience.org/library/papers/17522506 | PubMed |
| 16 | 16557381 | Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. | J Cancer Res Clin Oncol | 2006 | https://conductscience.org/library/papers/16557381 | PubMed |
| 17 | 10613728 | Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. | Hepatology | 2000 | https://conductscience.org/library/papers/10613728 | PubMed |
| 18 | 10915728 | Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. | Hepatology | 2000 | https://conductscience.org/library/papers/10915728 | PubMed |
| 19 | 11352697 | Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. | Ann Intern Med | 2001 | https://conductscience.org/library/papers/11352697 | PubMed |
| 20 | 11668491 | Estimating the world cancer burden: Globocan 2000. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11668491 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39212922 | Hepatocellular Carcinoma: Surgical Management and Evolving Therapies. | Cancer Treat Res | 2024 | https://conductscience.org/library/papers/39212922 | PubMed |
| 33527025 | IFN-α facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma. | Am J Transl Res | 2021 | https://conductscience.org/library/papers/33527025 | PubMed |
| 29358721 | Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29358721 | PubMed |
| 26595239 | Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer. | Immunology | 2016 | https://conductscience.org/library/papers/26595239 | PubMed |
| 26584517 | Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells. | Sci Rep | 2015 | https://conductscience.org/library/papers/26584517 | PubMed |
| 25279210 | Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis. | Mol Clin Oncol | 2014 | https://conductscience.org/library/papers/25279210 | PubMed |
| 24696596 | Systemic therapy of hepatocellular carcinoma: current status and future perspectives. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24696596 | PubMed |
| 23569435 | Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma. | Int J Biol Sci | 2013 | https://conductscience.org/library/papers/23569435 | PubMed |
| 23025904 | Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma. | BMC Cancer | 2012 | https://conductscience.org/library/papers/23025904 | PubMed |
| 22752423 | Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma. | J Gastrointest Cancer | 2012 | https://conductscience.org/library/papers/22752423 | PubMed |
| 22056812 | Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). | Cancer Lett | 2012 | https://conductscience.org/library/papers/22056812 | PubMed |
| 19812400 | MicroRNA expression, survival, and response to interferon in liver cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19812400 | PubMed |
| 19155200 | Surgical treatment for hepatocellular carcinoma in cirrhotic patients. Guide to the selection and decision-making process in a context of multimodal strategy. | Clin Transl Oncol | 2009 | https://conductscience.org/library/papers/19155200 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17522507
GET https://conductscience.org/api/papers/v1/17522507/references?page=2